EPHX2 and Alzheimer disease: Those findings emphasized the microbiota and peripheral inflammation's significant role in neurodegenerative diseases and, particularly, their influence on AD hallmarks [90-92], suggesting that the gut microbiome significantly impacts in its pathology development and that sEH inhibition has a beneficial effect on AD mice model implicated gut-brain axis modulation (Fig. 14).